Skip to main content
Seeing the difference Ac-225 could make to cancer patients made Raina Setzer want to come to ORNL to directly work with the isotope. Credit: Allison Peacock/ORNL, U.S. Dept. of Energy

Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.

Mike Huettel

Mike Huettel is a cyber technical professional. He also recently completed the 6-month Cyber Warfare Technician course for the United States Army, where he learned technical and tactical proficiency leadership in operations throughout the cyber domain.

ORNL identity science researcher Nell Barber works on a facial recognition camera. Credit: Genevieve Martin/ORNL, U.S. Dept. of Energy

Though Nell Barber wasn’t sure what her future held after graduating with a bachelor’s degree in psychology, she now uses her interest in human behavior to design systems that leverage machine learning algorithms to identify faces in a crowd.

Logan Sturm, Alvin M. Weinberg Fellow at ORNL, creates a mashup between additive manufacturing and cybersecurity research. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

How an Alvin M. Weinberg Fellow is increasing security for critical infrastructure components

Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Sandra Davern performs cell based assays to evaluate cell death and DNA damage in response to radiation in order to gain a better understanding of how radioisotope nanoparticles affect the human body.

When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.